May 02, 2025

Use of Ruxolitinib to Resolve Ciltacabtagene Autoleucel–Induced Parkinsonism in Patients With Multiple Myeloma

Ruxolitinib may prove to be an effective treatment of parkinsonism arising from ciltacabtagene autoleucel treatment for patients with multiple myeloma, according to the results of two case studies pub...

The ASCO Post

May 02, 2025

CRP in CSF Accurately Detects Meningitis, Study 

CRP in cerebrospinal fluid showed high accuracy in diagnosing bacterial meningitis, helping doctors detect cases even when standard CSF markers appear normal.

Conexiant

May 01, 2025

Phthalates Linked to Cardiovascular Mortality Globally

Researchers linked di-2-ethylhexylphthalate plastic exposure to over 350,000 cardiovascular deaths and 10 million years of life lost, supporting calls for international regulatory measures.

Conexiant

May 01, 2025

Health Care Faces New Immigration Reality

Health care facilities face new challenges as sensitive locations policy protecting them from immigration enforcement was rescinded in January 2025, requiring new protocols for patient protection.

Conexiant

May 01, 2025

Psilocybin Shows Promise for Parkinson's Disease

First clinical trial demonstrates psilocybin therapy significantly improves depression, anxiety, and motor symptoms.

Conexiant

May 01, 2025

Spotlight on Technology & Technique: LYNX LIO Offers Pattern Delivery and Portability

Discover the revolutionary LYNX, a laser indirect ophthalmoscope providing mobile, precise, and comfortable retinal treatments with integrated headset and wireless tablet interface.

Ophthalmology Management

April 30, 2025

Myelin Proteins Altered After Splice Inhibition, Study

Inhibiting a protein called hnRNP A1 disrupted myelin repair in mouse brains without causing noticeable behavioral changes, according to a new study exploring its effects across multiple brain regions.

Conexiant

April 30, 2025

Sitting Raises Neck Pain Risk by Over 80%

"Targeted preventative measures, particularly for high-risk groups like [women] and employees, are necessary."

Conexiant

April 29, 2025

Progression in Parkinson’s

α-Synuclein PET tracer shows potential to diagnose and monitor the disease

The Pathologist